Home › IGA Glomerulonephritis › Georgia
IGA Glomerulonephritis clinical trials in Georgia
5 studies for IGA Glomerulonephritis are looking for participants at sites in Georgia.
Cities in Georgia
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Investigator Site #1, Lawrenceville
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Oct 1, 2026 · NCT06419205A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- American Clinical Trials, Acworth
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07146906Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Fides Clinical Research, Atlanta
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- Georgia Nephrology Research Inst, Lawrenceville
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Jul 29, 2026 · NCT06797518Study of BHV-1400 in IgA Nephropathy
- Site-008, Lawrenceville
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.